These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 3403885

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Trientine for Wilson's disease.
    Med Lett Drugs Ther; 1986 Jul 04; 28(717):67. PubMed ID: 3724656
    [No Abstract] [Full Text] [Related]

  • 4. [Triethylene tetramine in Wilson's disease].
    Rave D, Vengrover D, Kleinman J, Leitersdorf E.
    Harefuah; 1986 Feb 16; 110(4):178-9. PubMed ID: 3721331
    [No Abstract] [Full Text] [Related]

  • 5. The management of Wilson's disease with trienthylene tetramine 2HC1 (Trien 2HC1).
    Walshe JM.
    Prog Clin Biol Res; 1979 Feb 16; 34():271-80. PubMed ID: 531055
    [No Abstract] [Full Text] [Related]

  • 6. [Trientin in Wilson's disease. Therapeutic possibilities in patients who cannot tolerate penicillamine].
    Ritland S.
    Tidsskr Nor Laegeforen; 1987 Aug 10; 107(22):1770-1. PubMed ID: 3660361
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of Wilson's disease.
    Brewer GJ, Yuzbasiyan-Gurkan V, Young AB.
    Semin Neurol; 1987 Jun 10; 7(2):209-20. PubMed ID: 3332455
    [No Abstract] [Full Text] [Related]

  • 8. [Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu].
    Günther K, Siegemund R, Lössner J, Kühn HJ.
    Radiobiol Radiother (Berl); 1988 Jun 10; 29(2):226-9. PubMed ID: 3399664
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
    Haslam RH, Sass-Kortsak A, Stout W, Berg M.
    Dev Pharmacol Ther; 1980 Jun 10; 1(5):318-24. PubMed ID: 7438976
    [Abstract] [Full Text] [Related]

  • 10. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease.
    Scheinberg IH, Jaffe ME, Sternlieb I.
    N Engl J Med; 1987 Jul 23; 317(4):209-13. PubMed ID: 3600712
    [Abstract] [Full Text] [Related]

  • 11. The management of pregnancy in Wilson's disease treated with trientine.
    Walshe JM.
    Q J Med; 1986 Jan 23; 58(225):81-7. PubMed ID: 3704107
    [Abstract] [Full Text] [Related]

  • 12. Neurological abnormalities in Wilson's disease are reversible.
    Lingam S, Wilson J, Nazer H, Mowat AP.
    Neuropediatrics; 1987 Feb 23; 18(1):11-2. PubMed ID: 3561699
    [Abstract] [Full Text] [Related]

  • 13. Preparation of and clinical experiences with trien for the treatment of Wilson's disease in absolute intolerance of D-penicillamine.
    Harders H, Cohnen E.
    Proc R Soc Med; 1977 Feb 23; 70 Suppl 3(Suppl 3):10-2. PubMed ID: 122652
    [No Abstract] [Full Text] [Related]

  • 14. The mechanisms of penicillamine, trientine, and zinc in the treatment of Wilson's disease.
    Yarze JC.
    Am J Gastroenterol; 1995 Jun 23; 90(6):1026. PubMed ID: 7771405
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Two male patients with Wilson's disease treated using trientine and iron reduction therapy.
    Hayashi H, Ueno T, Yano M, Okada T, Mabuchi H.
    J Gastroenterol Hepatol; 2005 Oct 23; 20(10):1627-8. PubMed ID: 16174091
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neurological Wilson's disease.
    McIntyre N.
    Q J Med; 1993 May 23; 86(5):349-50. PubMed ID: 8327653
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.